Guest Editor, Dr. Daniel Roche, University of Maryland Baltimore
Editor-in-Chief, Dr. Sherwood Brown, The University of Texas Southwestern
Dear Colleagues,
The Journal of Dual Diagnosis (2021 Impact Factor: 2.3) invites authors to submit original research or a review article to a new special issue focusing on the intersection of trauma and substance misuse across the lifespan. Both substance misuse and trauma are broadly defined for the purposes of this issue. Papers can include the study of any substance and a variety of trauma topics, e.g. childhood trauma/early life adversity, subthreshold PTSD, comorbid diagnosis of SUD/AUD and PTSD, trauma stemming from racial discrimination, etc.
Our last special issue, published in 2020 on cannabis (https://www.tandfonline.com/toc/wjdd20/16/1), has been highly viewed and cited, and we hope your contribution can make this edition equally successful. Please feel free to contact other colleagues as collaborators on this manuscript, and this is also a great opportunity to give trainees an opportunity to publish.
Timeline for submission and publication: Manuscripts may be submitted between August 1, 2022 and April 1st, 2023. Manuscripts will be published online as they are accepted and subsequently collected in a special issue that will be published in November 2023.
Contact information: Questions on this special issue can be sent directly to the Guest Editor, Dr. Daniel Roche at: [email protected]. Dr. Roche encourages authors to discuss potential topics with him before submitting.
Types of articles to be included: The Journal of Dual Diagnosis will consider the following types of articles: full length articles, brief reports, literature reviews, editorials & commentaries, clinical reviews, and letters to the editors. For this special issue, priority will be given to empirical full-length and brief reports, but review papers (meta-analysis, systematic, and narrative) and hybrid review-empirical research manuscripts are also encouraged.
